Bristol-Myers Squibb will buy Celgene for more than $ 90 billion , debt inclusive .
In early January 2019 , the company announced it would be acquired by Bristol-Myers Squibb for $ 74 billion ( $ 95 billion including debt ) , in a deal that would become the largest pharmaceutical-company acquisition e
Celgene